Trevena, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Pipeline
    • Overview
    • TRV045
    • TRV250
    • TRV734
  • Products
    • OLINVYK® (oliceridine) injection
  • Medical Affairs
    • Investigator-Initiated Trials
    • Contact Medical Information
  • Publications
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial Info
    • Stock Info
    • Resources
    • Governance
  • Careers
  • Contact
    • Contact Medical Information
    • Whistleblower Hotline

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events & Presentations
    • Presentations
    • IR Calendar
  • Financial Info
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Stock Info
    • Quote
    • Analyst Coverage
    • IRS Form 8937
  • Resources
    • Email Alerts
    • Contacts
    • FAQ
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Governance Documents

Trevena Announces Receipt of Milestone Payment From Partner in China Jiangsu Nhwa Pharmaceutical

May 31, 2023 7:00am EDT

Trevena Regains Compliance with Nasdaq Listing and Reaffirms Expected Near-Term Milestones

May 30, 2023 7:00am EDT

Trevena Reports First Quarter 2023 Results and Provides Business Update

May 15, 2023 7:00am EDT

Trevena to Release First Quarter 2023 Financial Results on May 15, 2023

May 09, 2023 7:00am EDT

Trevena Announces Approval of OLINVYK in China

May 08, 2023 7:00am EDT

Trevena to Participate in Three Upcoming Conferences

May 03, 2023 7:00am EDT

Trevena Announces Initial Topline OLINVYK Data from ~200 Patient Real-World Clinical Outcomes Study

Mar 30, 2023 7:02am EDT

Trevena Reports Fourth Quarter 2022 Results and Provides Business Update

Mar 30, 2023 7:00am EDT

Trevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023

Mar 27, 2023 7:00am EDT

Trevena Initiates Targeted Proof-of-Concept Study to Evaluate TRV045 as a Potential Treatment for Epilepsy and Other CNS Disorders

Mar 07, 2023 7:00am EST
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...32
Next
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
© 2023 Trevena, Inc. All Rights Reserved.
Privacy Policy Terms of Use Disclaimer Sitemap